Kestra Private Wealth Services LLC Cuts Stock Position in Synopsys, Inc. $SNPS

Kestra Private Wealth Services LLC cut its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS) by 30.8% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,050 shares of the semiconductor company’s stock after selling 1,360 shares during the quarter. Kestra Private Wealth Services LLC’s holdings in Synopsys were worth $1,209,000 as of its most recent SEC filing.

Several other large investors have also made changes to their positions in the business. Sankala Group LLC bought a new position in Synopsys in the 4th quarter worth approximately $25,000. Thurston Springer Miller Herd & Titak Inc. purchased a new position in shares of Synopsys in the fourth quarter worth $28,000. Caitong International Asset Management Co. Ltd purchased a new position in shares of Synopsys in the fourth quarter worth $28,000. Atlas Capital Advisors Inc. bought a new position in shares of Synopsys during the fourth quarter worth $32,000. Finally, Phillip James Consulting Co. bought a new position in shares of Synopsys during the fourth quarter worth $36,000. 85.47% of the stock is currently owned by hedge funds and other institutional investors.

Synopsys Trading Down 0.3%

SNPS opened at $446.07 on Wednesday. The firm has a market cap of $85.41 billion, a P/E ratio of 103.26, a P/E/G ratio of 2.63 and a beta of 1.22. Synopsys, Inc. has a 12 month low of $376.18 and a 12 month high of $651.73. The company has a current ratio of 1.43, a quick ratio of 1.32 and a debt-to-equity ratio of 0.33. The stock has a 50-day moving average of $483.72 and a 200 day moving average of $461.78.

Synopsys (NASDAQ:SNPS) last issued its quarterly earnings data on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.15 by $0.20. The business had revenue of $2.28 billion for the quarter, compared to the consensus estimate of $2.25 billion. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.The company’s quarterly revenue was up 41.9% compared to the same quarter last year. During the same period in the prior year, the business posted $3.67 earnings per share. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. As a group, research analysts forecast that Synopsys, Inc. will post 10.65 EPS for the current year.

Insiders Place Their Bets

In other Synopsys news, CEO Sassine Ghazi sold 14,603 shares of Synopsys stock in a transaction on Monday, June 15th. The shares were sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the completion of the transaction, the chief executive officer directly owned 75,020 shares of the company’s stock, valued at $34,431,179.20. The trade was a 16.29% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Shelagh Glaser sold 3,394 shares of the business’s stock in a transaction on Friday, June 12th. The shares were sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the transaction, the chief financial officer owned 14,358 shares in the company, valued at $6,461,387.16. This trade represents a 19.12% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.56% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

SNPS has been the topic of a number of research reports. Morgan Stanley lifted their price target on shares of Synopsys from $480.00 to $525.00 and gave the company an “equal weight” rating in a report on Thursday, May 28th. Piper Sandler raised shares of Synopsys from a “neutral” rating to an “overweight” rating and increased their price objective for the company from $450.00 to $550.00 in a report on Tuesday, June 23rd. Stifel Nicolaus raised their price objective on Synopsys from $550.00 to $600.00 and gave the company a “buy” rating in a research report on Thursday, May 28th. Bank of America lifted their target price on Synopsys from $515.00 to $600.00 and gave the stock a “buy” rating in a report on Thursday, May 28th. Finally, Needham & Company LLC reiterated a “buy” rating and issued a $580.00 target price on shares of Synopsys in a research report on Thursday, May 28th. Ten analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, Synopsys currently has a consensus rating of “Moderate Buy” and a consensus price target of $570.06.

Synopsys Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.